Glaukos Corporation (GKOS) vs Smith & Nephew SNATS, Inc. (SNN)
- Glaukos Corporation GKOS 225.73 +2.61%
- Smith & Nephew SNATS, Inc. SNN 31.12 −2.78%
Glaukos Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Glaukos Corporation and Smith & Nephew SNATS, Inc. are of similar size ($13.4B and $13.0B). Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Smith & Nephew SNATS, Inc. trades at 38.9×. Glaukos Corporation grew revenue faster over the last twelve months: 46.9% against 4.81%. Smith & Nephew SNATS, Inc. has the higher net margin (6.71% vs −24.6%) and the higher return on invested capital (0.00% vs −24.6%). Across the 20 metrics below, Smith & Nephew SNATS, Inc. leads on 13 and Glaukos Corporation on 7.
Valuation
Profitability
| Metric | GKOS | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.13% | 70.52% | 57.76% |
| Operating margin | (25.52%) | 0.00% | (15.07%) |
| Net margin | (24.60%) | 6.71% | (14.45%) |
| Free cash flow margin | 5.22% | 0.00% | (3.88%) |
| Return on equity | (22.84%) | 0.00% | (10.35%) |
| Return on assets | (17.16%) | 0.00% | (17.26%) |
| Return on invested capital | (24.60%) | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack